Select ImmunoGenomics - Ownership and Business Overview

Information TechnologyCompany

Select ImmunoGenomics Ownership

Who owns Select ImmunoGenomics?

Select ImmunoGenomics is owned by GeneCentric Therapeutics. It was acquired on August 15, 2019.

Select ImmunoGenomics Business Overview

Where is Select ImmunoGenomics headquartered?

Select ImmunoGenomics is headquartered in Apex, North Carolina.

What sector is Select ImmunoGenomics in?

Select ImmunoGenomics is an information technology company.

Information Technology M&A Summary in 2019

Out of 60 sectors in the Mergr database, information technology ranked 1 in number of deals in 2019. The largest information technology acquisition in 2019 was Total System Services - which was acquired by Global Payments for $21.5B.

Join Mergr to view all 825 acquisitions of information technology companies in 2019, including 110 acquisitions by private equity firms, and 715 by strategics.

Select ImmunoGenomics, Inc.

5448 Apex Peakway,
Apex, North Carolina 27502
United States,
www.selectimmunogenomics.com

Select ImmunoGenomics, Inc. is a provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs. Select ImmunoGenomics is based in Apex, North Carolina.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.